Staff working in brain tumours at Salford Royal

National accolade for Manchester brain tumour services

Salford Royal’s brain tumour services have received a national award for excellence in patient care.

Manchester’s brain tumour centre has been recognised as a Tessa Jowell Centre of Excellence following rigorous expert-led assessments by the Tessa Jowell Brain Cancer Mission.

The national prestigious accolade was awarded to Salford Royal and The Christie and was measured on a range of criteria, including excellent clinical practice and training opportunities; emphasis on patient quality of life; providing clinical trials and offering a high standard of research opportunities.

Salford Royal Consultant and the Manchester brain tumour service lead Miss Tina Karabatsou, said: “I would like to thank each member of the neurooncology team for their commitment, passion and dedication and our management team who have been brilliant in supporting us as well as our patients and their families.

“We are honoured to receive this Centre of Excellence Designation on behalf of the amazing multi-disciplinary team dedicated to caring for brain tumour patients from across Greater Manchester and Cheshire. The designation reflects the individual contributions of many people, working at Salford Royal, The Christie and in the community, as well as researchers at The University of Manchester, the Manchester Cancer Research Centre and the Geoffrey Jefferson Brain Research Centre.”

Led by a committee of experts in the field and virtual site visits, the assessments were backed up by patient feedback about the care they received. It is one of 10 hospitals across the UK to receive the recognition.

There are more than 12,000 people diagnosed every year with a primary brain tumour in the UK, and approximately 600 new patients with primary brain tumours seeking treatment in Manchester.

Jess Mills, Co-Founder of the Tessa Jowell Brain Cancer Mission and Tessa’s daughter, said: “We are thrilled to have awarded Manchester’s brain tumour service for its excellent ongoing work for patients and commitment to support other centres in reaching the same level of Excellence.

“Shockingly, the UK still has one of the worst cancer survival rates in Europe, but in time, the Tessa Jowell Centres will make the UK a global leader in the treatment and care of brain tumour patients. We have a long way to go until the cutting edge of science is delivered to every patient, but this is a huge and transformational first step.”